Showing all 4 results
Silodosin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pharmaceutical ingredient.
Active Ingredient Strength Primary Clinical Function Silodosin INN/Ph.Eur. 8 mg Global Clinical Standard: Maximum adult daily dose for the rapid relief of lower urinary tract symptoms (LUTS) associated with BPH. Excipients Mannitol / Pregelatinized Starch / Sodium Stearyl Fumarate / Hypromellose / Titanium Dioxide Diluent / Binder / Lubricant / Film-Coating (Engineered for highly synchronized gastric dissolution and optimal bioavailability) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for high-compliance 30-day urology dispensing regimens).
Tamsulosin & Dutasteride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Bilayer Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant and child-resistant Alu-Alu blister strips to ensure the absolute stability of both the kinetic polymer matrix and the sensitive hormonal API.
Active Ingredient Strength Primary Clinical Function Tamsulosin Hydrochloride USP/Ph.Eur. 0.4 mg (Modified-Release) Continuous 24-hour uro-selective alpha-1A blockade for immediate symptom relief. Dutasteride USP/Ph.Eur. 0.5 mg Dual 5-alpha-reductase inhibition for profound DHT suppression and prostate volume reduction. Excipients Hypromellose (HPMC) / Butylated Hydroxytoluene (BHT) / Microcrystalline Cellulose / Magnesium Stearate SR Polymer matrix for Tamsulosin / Antioxidant stabilizer for solid-state Dutasteride (Engineered for strict segregation) Tamsulosin & Finasteride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Bilayer Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant and child-resistant Alu-Alu blister strips to ensure the absolute stability of both the kinetic polymer matrix and the sensitive hormonal API.
Active Ingredient Strength Primary Clinical Function Tamsulosin Hydrochloride USP/Ph.Eur. 0.4 mg (Modified-Release) Continuous 24-hour uro-selective alpha-1A blockade for immediate symptom relief. Finasteride USP/Ph.Eur. 5 mg Targeted Type II 5-alpha-reductase inhibition for profound DHT suppression and prostate shrinkage. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Sodium Starch Glycolate / Magnesium Stearate SR Polymer matrix for Tamsulosin / Diluent for Finasteride (Engineered for strict kinetic segregation) Tamsulosin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Gel-Matrix Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the hygroscopic polymers.
Active Ingredient Strength Primary Clinical Use Tamsulosin Hydrochloride USP/Ph.Eur. 0.4 mg (Modified-Release Tablet) Premium Global Standard: Target once-daily, food-independent adult dose for BPH. Excipients Macrogol (Polyethylene Glycol) / Magnesium Stearate / Hypromellose / Iron Oxide Advanced Non-Ionic Gel Matrix / Lubricant / Film Coat (Engineered for strict 24-hour continuous diffusion)
